Navigation Links
Venaxis Appoints SomaLogic CMO and former Pfizer Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors
Date:4/18/2013

CASTLE ROCK, Colo., April 18, 2013 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, protein biomarker-based assay for appendicitis, today announced the appointment of Stephen A. Williams , M.D., Ph.D., Chief Medical Officer at SomaLogic, to the Company's Board of Directors.  Dr. Williams brings his experience in diagnostic imaging and biomarker discovery to the Venaxis Board.

Steve Lundy , President and CEO of Venaxis, stated, "We are happy to welcome Steve to our Board and look forward to the benefit of his deep experience, both in diagnostic imaging, which is relevant to our market development and commercial strategy for the APPY1 Test, as well as in clinical biomarker validation, which will be instrumental to us in our evaluation and development of future Venaxis products."

Dr. Williams stated, "The APPY1 Test is an excellent example of how characterization of clinically relevant biomarkers can produce useful tools for addressing important diagnostic challenges.  With the potential to reduce the safety risks associated with current diagnostic imaging techniques in the emergency setting, I believe there is significant clinical need and utility for the APPY1 Test.  I am excited to join the Venaxis Board and to support the further development and commercialization of this, as well as potential future, biomarker-based diagnostic products."

Dr. Williams joined SomaLogic in 2009 as Chief Medical Officer.  Prior to his time at SomaLogic, Dr. Williams trained as a physician at Charing Cross and Westminster Medical School, University of London, and following his internships, returned to the same institution for a Ph.D. in medicine and physiology.  He s
'/>"/>

SOURCE Venaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AspenBio Pharma Changes Company Name to Venaxis, Inc.
2. Venaxis to Present at 2013 BIO CEO and Investor Conference
3. Venaxis Presentation Rescheduled for 2013 BIO CEO and Investor Conference
4. Venaxis to Present at 25th Annual ROTH Conference
5. Venaxis Advances Pivotal U.S. Study and Accelerates European Market Development for APPY1 Blood-based Appendicitis Test
6. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
7. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
8. Nephros Appoints John C. Houghton as President and Chief Executive Officer
9. Elsevier Appoints New President of Elsevier CPM Resource Center
10. GenWay Biotech Appoints New Vice President of Custom/OEM
11. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... PLANTATION, Fla. , July 22, 2014  Neurotrope ... has signed a world-wide, exclusive license agreement with the ... ( Mount Sinai ) to ... use of Bryostatin-1 in the treatment of Niemann-Pick Type ... who are afflicted with Alzheimer-like symptoms. The license also ...
(Date:7/22/2014)... , July 22, 2014  According to the ... their children spend on digital devices. An AOA survey ... of 10 and 17 estimate they use an electronic ... a separate AOA survey of parents revealed that only ... electronic device for that same amount of time. Eye ...
(Date:7/22/2014)... MARCOS, Texas , July 22, 2014 Quantum Materials ... and Mr. John Heaton to the Board of ... by Dr. Ghassan Jabbour , QMC Chief Science Officer and ... Michael Wong of Rice University and Mr. Tomio ... Japan . " Quantum Materials welcomes ...
Breaking Medicine Technology:Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4
... Jan. 3, 2012  theVisualMD, www.thevisualmd.com , the world,s leading ... initiative, The 9 Visual Rules of Wellness. Quest Diagnostics (NYSE: ... testing, information and services, is the official sponsor of the ... 9 Visual Rules of Wellness aim to bring readers a ...
...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) and Eisai ... the Complete Response Letter (CRL) issued by the US Food ... Drug Application (NDA). Lorcaserin is intended for weight management, including ... are obese (Body Mass Index, or BMI, >30) or patients ...
Cached Medicine Technology:theVisualMD Launches a Revolutionary New Visual Path to Wellness 2theVisualMD Launches a Revolutionary New Visual Path to Wellness 3theVisualMD Launches a Revolutionary New Visual Path to Wellness 4Arena Submits Response to FDA Complete Response Letter for Lorcaserin 2Arena Submits Response to FDA Complete Response Letter for Lorcaserin 3Arena Submits Response to FDA Complete Response Letter for Lorcaserin 4Arena Submits Response to FDA Complete Response Letter for Lorcaserin 5Arena Submits Response to FDA Complete Response Letter for Lorcaserin 6
(Date:7/22/2014)... 22, 2014) The American Society of Hematology (ASH) ... School of Medicine, and Robert P. Hebbel, MD, of ... Ernest Beutler Lecture and Prize for their significant research ... The Ernest Beutler Lecture, named for the late Ernest ... for more than 50 years, is a two-part lectureship ...
(Date:7/22/2014)... American Society of Hematology (ASH) will present the Society,s ... Lifetime Achievement in Hematology, to Kanti R. Rai, MD, ... of Medicine for his 50-year career combining landmark clinical ... exceptional patient care. , The Wallace H. Coulter ... an individual who has been a vital contributor to ...
(Date:7/22/2014)... New guidelines on cholesterol treatment and cardiovascular risk assessment ... of dying from atherosclerotic cardiovascular disease or of having ... a similar risk profile (based on age, smoking history, ... this finding for when and how aggressively to treat ... Journal of Men,s Health , a peer-reviewed publication from ...
(Date:7/22/2014)... The Entertainment Industries Council, Inc. ( EIC ... and recognition activities for thousands of entertainment and news ... recovery. On July 24, 2014, at 8pm, the new ... resources with a special mention of the Substance Abuse ... at the end of the show. , ...
(Date:7/22/2014)... lacrosse players are facing an increasing number of injuries ... finds. Although the most common injuries are sprains ... report. They note a better understanding of why these ... protect student athletes. "Concern over concussions in both ... more about these injuries," said study co-author Dawn Comstock ...
Breaking Medicine News(10 mins):Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Injuries on the Increase in High School Lacrosse, Study Shows 2Health News:Injuries on the Increase in High School Lacrosse, Study Shows 3
... redesigned website that allows physicians and dentists to request disability ... , ... San Clemente, CA (PRWEB) ... [disability insurance __title__ disability insurance] and life insurance brokerage service, ...
... the launch of its kidney disease education and screening program in New ... ... American Kidney Fund today announced the launch of its www.kidneyfund.org ... , , ,The American Kidney Fund,s MIKE program (Minority Intervention and Kidney ...
... studies, reveals depression medications containing SSRIs can interrupt dopamine levels and ... ... St. Charles, IL (PRWEB) July 31, 2008 -- Recent trends ... are at an all time high. In fact, according to a ...
... Honda is hosting a blood drive at its Phillipsburg location on ... ... Phillipsburg, NJ (PRWEB) July 31, 2008 -- Phillipsburg Easton Honda is ... 9th from 11:00AM to 1:45PM., , , , ,"Demand for blood ...
... gives a new cellulite solution the edge to help the skin repair itself ... ... photo-damaged skin can be a frustrating part of your life. There are skin ... and age spots. , , ,These ailments can be hard to heal on ...
... Benjamin, MD, FACP, FACEP (E), Executive Director, ... 30 The American Public,Health Association applauds the ... Smoking and Tobacco Control Act with an overwhelming,bipartisan ... of,Americans, particularly children, by giving the Food and ...
Cached Medicine News:Health News:New Website Helps Doctors and Dentists Locate Disability Insurance 2Health News:New Website Helps Doctors and Dentists Locate Disability Insurance 3Health News:American Kidney Fund Launches Screening Program in New York City 2Health News:Lyriana Announces Antidepressants Now Linked to Declining Libido in Women 2Health News:Lyriana Announces Antidepressants Now Linked to Declining Libido in Women 3Health News:Lyriana Announces Antidepressants Now Linked to Declining Libido in Women 4Health News:Phillipsburg Easton Honda to Host Miller-Keystone Blood Drive 2Health News:Phillipsburg Easton Honda to Host Miller-Keystone Blood Drive 3Health News:New Skin Revitalizing Product Uses Naturally Occurring Serum for the Repair of Sun Damaged Skin 2Health News:New Skin Revitalizing Product Uses Naturally Occurring Serum for the Repair of Sun Damaged Skin 3
... Flowmaster. It is a new portable digital flowmeter ... of use, simplicity and cost effectiveness are top ... now very easy to give a patient some ... and data will be send wirelessly to the ...
... the second generation of Urocap, ... zeroing, starting, stopping and printing. ... uroflowmetry parameters with superior low ... provides standard ICS nomenclature normative ...
... Uro-Guide Open Tip Ureteral ... silicone over-the-wire stents and ... design with an open ... of time-tested biocompatible silicone ...
... patient position during surgery is key to ... procedures. Not every patient is able to ... movements can compromise the procedure or necessitate ... Rousseau chin-lift stabilizer eliminates the "drifting that ...
Medicine Products: